Literature DB >> 21532638

Connective tissue diseases: targeting B cells in SLE: good news at last!

Iñaki Sanz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21532638     DOI： 10.1038/nrrheum.2011.48

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  8 in total

1.  Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells.

Authors:  Min Yang; Lingyun Sun; Shengjun Wang; King-Hung Ko; Huaxi Xu; Bo-Jian Zheng; Xuetao Cao; Liwei Lu
Journal:  J Immunol       Date:  2010-03-05       Impact factor: 5.422

2.  Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.

Authors:  Sandra V Navarra; Renato M Guzmán; Alberto E Gallacher; Stephen Hall; Roger A Levy; Renato E Jimenez; Edmund K-M Li; Mathew Thomas; Ho-Youn Kim; Manuel G León; Coman Tanasescu; Eugeny Nasonov; Joung-Liang Lan; Lilia Pineda; Z John Zhong; William Freimuth; Michelle A Petri
Journal:  Lancet       Date:  2011-02-04       Impact factor: 79.321

3.  Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells.

Authors:  Yohei Iwata; Takashi Matsushita; Mayuka Horikawa; David J Dilillo; Koichi Yanaba; Guglielmo M Venturi; Paul M Szabolcs; Steven H Bernstein; Cynthia M Magro; Armistead D Williams; Russell P Hall; E William St Clair; Thomas F Tedder
Journal:  Blood       Date:  2010-10-20       Impact factor: 22.113

Review 4.  Targeting BLyS in rheumatic disease: the sometimes-bumpy road from bench to bedside.

Authors:  William Stohl; Jean L Scholz; Michael P Cancro
Journal:  Curr Opin Rheumatol       Date:  2011-05       Impact factor: 5.006

5.  A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus.

Authors:  Daniel J Wallace; William Stohl; Richard A Furie; Jeffrey R Lisse; James D McKay; Joan T Merrill; Michelle A Petri; Ellen M Ginzler; W Winn Chatham; W Joseph McCune; Vivian Fernandez; Marc R Chevrier; Z John Zhong; William W Freimuth
Journal:  Arthritis Rheum       Date:  2009-09-15

6.  CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.

Authors:  Paul A Blair; Lina Yassin Noreña; Fabian Flores-Borja; David J Rawlings; David A Isenberg; Michael R Ehrenstein; Claudia Mauri
Journal:  Immunity       Date:  2010-01-14       Impact factor: 31.745

7.  Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study.

Authors:  Annett M Jacobi; Weiqing Huang; Tao Wang; William Freimuth; Inaki Sanz; Richard Furie; Meggan Mackay; Cynthia Aranow; Betty Diamond; Anne Davidson
Journal:  Arthritis Rheum       Date:  2010-01

8.  Defective B cell tolerance checkpoints in systemic lupus erythematosus.

Authors:  Sergey Yurasov; Hedda Wardemann; Johanna Hammersen; Makoto Tsuiji; Eric Meffre; Virginia Pascual; Michel C Nussenzweig
Journal:  J Exp Med       Date:  2005-02-28       Impact factor: 14.307
  8 in total
  4 in total

1.  Protein kinase Cβ is required for lupus development in Sle mice.

Authors:  David Oleksyn; Mary Pulvino; Jiyong Zhao; Ravi Misra; Aram Vosoughi; Scott Jenks; Christopher Tipton; Frances Lund; George Schwartz; Bruce Goldman; Chandra Mohan; Kamal Mehta; Madhu Mehta; Michael Leitgets; Ignacio Sanz; Luojing Chen
Journal:  Arthritis Rheum       Date:  2013-04

2.  Role of microRNA-15a in autoantibody production in interferon-augmented murine model of lupus.

Authors:  Yao Yuan; Siddha Kasar; Chingiz Underbayev; Daniel Vollenweider; Erica Salerno; Sergei V Kotenko; Elizabeth Raveche
Journal:  Mol Immunol       Date:  2012-05-11       Impact factor: 4.407

3.  Advances in human B cell phenotypic profiling.

Authors:  Denise A Kaminski; Chungwen Wei; Yu Qian; Alexander F Rosenberg; Ignacio Sanz
Journal:  Front Immunol       Date:  2012-10-10       Impact factor: 7.561

4.  Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study.

Authors:  Dandan Wang; Jing Li; Yu Zhang; Miaojia Zhang; Jinyun Chen; Xia Li; Xiang Hu; Shu Jiang; Songtao Shi; Lingyun Sun
Journal:  Arthritis Res Ther       Date:  2014-03-25       Impact factor: 5.156
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.